| COMMON NAME |
MG-A271, MGA271 |
|---|---|
| SYNONYMS |
B7-H3;CD276;B7 homolog 3 |
| APPLICATIONS |
ELISA; Flow Cyt |
| RECOMMENDED DILUTIONS |
Flow Cyt 1:100 |
| FORMULATION & RECONSTITUTION |
Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution. |
| HOST SPECIES |
Humanized |
| IGG TYPE |
IgG1 |
| REACTIVITY |
Human |
| TARGET | |
| UNIPROT ID |
Q5ZPR3 |
| DESCRIPTION |
Anti-B7-H3 (enoblituzumab biosimilar) mAb |
| DELIVERY |
In Stock |
| STORAGE & SHIPPING |
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature. |
| BACKGROUND |
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
| USAGE |
Research use only |
Dima Biotech
SKU(재고 관리 코드):BME100010
Anti-B7-H3 (enoblituzumab biosimilar) mAb
Anti-B7-H3 (enoblituzumab biosimilar) mAb
PRODUCT DATA
IMAGES
Figure 1. ELISA plate pre-coated by 2 μg/ml (100 μl/well) Human B7-H3, mFc-His tagged protein (PME100012) can bind Anti-B7-H3 Neutralizing antibody in a linear range of 0.24-31.25 ng/ml.
Figure 2. HEK293 cell line transfected with irrelevant protein (B) and human B7-H3 (A) were surface stained with anti-B7H3 neutralizing antibody 1μg/ml (enoblituzumab) followed by Alexa 488-conjugated anti-human IgG secondary antibody.
